Hims & Hers Health, Inc. (HIMS) — 分析摘要
Hims & Hers Health, Inc.（HIMS）的市值为7.96十亿美元，最近一年的营收同比增长了+59.0%。净利润率为5.5%。当前市盈率为-601.2倍。
核心要点
- 营收同比变化+59.0%
- 净利润率5.5%
- 市盈率-601.2倍
与SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE板块的其他公司相比，HIMS的营收增长为+59.0%，市盈率为-601.2倍。
Hims & Hers Health, Inc. (HIMS)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
净利润由上一期盈利转为亏损。
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
行业
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
员工人数
2,442
总部
SAN FRANCISCO, CA
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。